Non-viral gene delivery of the oncotoxic protein NS1 for treatment of hepatocellular carcinoma.

Published on Jun 10, 2021in Journal of Controlled Release7.727
· DOI :10.1016/J.JCONREL.2021.04.023
Dominik Witzigmann16
Estimated H-index: 16
(University of Basel),
Philip Grossen8
Estimated H-index: 8
(University of Basel)
+ 15 AuthorsJörg Huwyler49
Estimated H-index: 49
(University of Basel)
Sources
Abstract
Abstract Hepatocellular carcinoma (HCC) is related to increasing incidence rates and poor clinical outcomes due to lack of efficient treatment options and emerging resistance mechanisms. The aim of the present study is to exploit a non-viral gene therapy enabling the expression of the parvovirus-derived oncotoxic protein NS1 in HCC. This anticancer protein interacts with different cellular kinases mediating a multimodal host-cell death. Lipoplexes (LPX) designed to deliver a DNA expression plasmid encoding NS1 are characterized using a comprehensive set of in vitro assays. The mechanisms of cell death induction are assessed and phosphoinositide-dependent kinase 1 (PDK1) is identified as a potential predictive biomarker for a NS1-LPX-based gene therapy. In an HCC xenograft mouse model, NS1-LPX therapeutic approach results in a significant reduction in tumor growth and extended survival. Data provide convincing evidence for future studies using a targeted NS1 gene therapy for PDK1 overexpressing HCC.
References62
Newest
#1Roy van der MeelH-Index: 21
#2Einar Sulheim (SINTEF)H-Index: 12
Last. Twan Lammers (UT: University of Twente)H-Index: 71
view all 6 authors...
Nanomedicines are extensively employed in cancer therapy. We here propose four strategic directions to improve nanomedicine translation and exploitation. (1) Patient stratification has become common practice in oncology drug development. Accordingly, probes and protocols for patient stratification are urgently needed in cancer nanomedicine, to identify individuals suitable for inclusion in clinical trials. (2) Rational drug selection is crucial for clinical and commercial success. Opportunistic ...
197 CitationsSource
#1Jayesh A. Kulkarni (UBC: University of British Columbia)H-Index: 14
#2Dominik Witzigmann (UBC: University of British Columbia)H-Index: 16
Last. Roy van der Meel (TU/e: Eindhoven University of Technology)H-Index: 21
view all 5 authors...
ConspectusDelivering nucleic acid-based therapeutics to cells is an attractive approach to target the genetic cause of various diseases. In contrast to conventional small molecule drugs that target gene products (i.e., proteins), genetic drugs induce therapeutic effects by modulating gene expression. Gene silencing, the process whereby protein production is prevented by neutralizing its mRNA template, is a potent strategy to induce therapeutic effects in a highly precise manner. Importantly, gen...
50 CitationsSource
#1Antonio Marchini (DKFZ: German Cancer Research Center)H-Index: 20
#2Laurent Daeffler (UDS: University of Strasbourg)H-Index: 9
Last. Jean Rommelaere (DKFZ: German Cancer Research Center)H-Index: 19
view all 5 authors...
Cancer cells utilize multiple mechanisms to evade and suppress anticancer immune responses creating a “cold” immunosuppressive tumor microenvironment. Oncolytic virotherapy is emerging as a promising approach to revert tumor immunosuppression and enhance the efficacy of other forms of immunotherapy. Growing evidence indicates that oncolytic viruses (OVs) act in a multimodal fashion, inducing immunogenic cell death and thereby eliciting robust anticancer immune responses. In this review, we summa...
23 CitationsSource
#1Jonas Buck (University of Basel)H-Index: 3
#2Philip Grossen (University of Basel)H-Index: 8
Last. Dominik Witzigmann (University of Basel)H-Index: 16
view all 5 authors...
Gene therapy is a promising strategy for the treatment of monogenic disorders. Non-viral gene delivery systems including lipid-based DNA therapeutics offer the opportunity to deliver an encoding gene sequence specifically to the target tissue and thus enable the expression of therapeutic proteins in diseased cells. Currently, available gene delivery approaches based on DNA are inefficient and require improvements to achieve clinical utility. In this Review, we discuss state-of-the-art lipid-base...
64 CitationsSource
#1Cuiling Qi (Guangdong Pharmaceutical University)H-Index: 14
#2Jinghua Cao (Guangdong Pharmaceutical University)H-Index: 3
Last. Bo Wei (SYSU: Sun Yat-sen University)H-Index: 15
view all 10 authors...
: Breast cancer is the most common malignant tumor among women, and the incidence and mortality of breast cancer has rapidly increased in recent years. Studies have indicated that high mobility group A1 (HMGA1), an important member of the HMGA family, plays a role in the pathogenesis and progression of malignant tumors, including breast cancer. This study aims to evaluate the effect of HMGA1 in breast cancer. Interestingly, we found that HMGA1 expression was significantly higher in breast cancer...
4 CitationsSource
#1Rebecca L. Siegel (ACS: American Cancer Society)H-Index: 67
#2Kimberly D. Miller (ACS: American Cancer Society)H-Index: 28
Last. Ahmedin Jemal (ACS: American Cancer Society)H-Index: 139
view all 3 authors...
Each year, the American Cancer Society estimates the numbers of new cancer cases and deaths that will occur in the United States and compiles the most recent data on cancer incidence, mortality, and survival. Incidence data, available through 2014, were collected by the Surveillance, Epidemiology, and End Results Program; the National Program of Cancer Registries; and the North American Association of Central Cancer Registries. Mortality data, available through 2015, were collected by the Nation...
9,230 CitationsSource
#1Haiqing Bai (UR: University of Rochester)H-Index: 2
#2Gillian M. Schiralli Lester (UR: University of Rochester)H-Index: 2
Last. David A. Dean (UR: University of Rochester)H-Index: 52
view all 4 authors...
Productive transfection and gene transfer require not simply the entry of DNA into cells and subsequent transcription from an appropriate promoter, but also a number of intracellular events that allow the DNA to move from the extracellular surface of the cell into and through the cytoplasm, and ultimately across the nuclear envelope and into the nucleus before any transcription can initiate. Immediately upon entry into the cytoplasm, naked DNA, either delivered through physical techniques or aft...
45 CitationsSource
#1Karsten GeletnekyH-Index: 19
#2Jacek HajdaH-Index: 4
Last. Jean Rommelaere (DKFZ: German Cancer Research Center)H-Index: 19
view all 27 authors...
Oncolytic virotherapy may be a means of improving the dismal prognosis of malignant brain tumors. The rat H-1 parvovirus (H-1PV) suppresses tumors in preclinical glioma models, through both direct oncolysis and stimulation of anticancer immune responses. This was the basis of ParvOryx01, the first phase I/IIa clinical trial of an oncolytic parvovirus in recurrent glioblastoma patients. H-1PV (escalating dose) was administered via intratumoral or intravenous injection. Tumors were resected 9 days...
74 CitationsSource
#1Kazutoshi Fujita (Osaka University)H-Index: 30
#2Yasutomo Nakai (Osaka University)H-Index: 21
Last. Norio Nonomura (Osaka University)H-Index: 55
view all 12 authors...
Inactivated Sendai virus particles (hemagglutinating virus of Japan envelope (HVJ-E)) have a novel antitumor effect: HVJ-E fused to prostate cancer cells via cell surface receptor causes apoptosis of prostate cancer cells in vitro and in vivo. HVJ-E also induces antitumor immunity by activating natural killer (NK) cells and cytotoxic T cells and suppressing regulatory T cells in vivo. We conducted an open-label, single-arm, phase I/II clinical trial in patients with castration-resistant prostate...
12 CitationsSource
#1Adam Doyle (U of T: University of Toronto)H-Index: 10
#2Morris Sherman (U of T: University of Toronto)H-Index: 71
The diagnosis of hepatocellular carcinoma (HCC) in many cases can be made on the basis of imaging alone. There are validated algorithms that have high specificity for the diagnosis of HCC. In these cases, a biopsy is not necessary for diagnosis. However, many practitioners still advocate the use of a biopsy in order to accumulate tissue that can be used for research purposes. In today’s ethical climate, this practice would be considered unethical unless patient consent is obtained. To subject a ...
3 CitationsSource
Cited By0
Newest